<DOC>
	<DOCNO>NCT00442767</DOCNO>
	<brief_summary>The primary objective study examine effect pramlintide give pre-meal insulin give meal take vs. standard therapy pre-meal insulin post-prandial glucose excursion . The secondary objective examine effect pramlintide insulin glucagon suppression type 1 diabetes .</brief_summary>
	<brief_title>Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide Children With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>type 1 diabetes diagnose T1DM least 1 year HbA1C le equal 8.5 % currently treat use insulin glargine without Humalog/ Novolog OR insulin pump hemoglobin equal great 12mg/dL otherwise healthy , EXCEPT T1DM treat hypothyroidism negative pregnancy test , case female lack supportive family evidence history chemical abuse BMI ( body mass index ) great 90th percentile OR le 10th percentile age patient poorly compliant current insulin management and/or prescribe self blood glucose monitoring patient experience recurrent severe hypoglycemia episode ( require assistance/ hospitalization ) past 6 month hypoglycemia unawareness confirm diagnosis gastroparesis , and/ require medication stimulate gastrointestinal motility pregnant lactating patient , patient plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>pediatric</keyword>
	<keyword>juvenile</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>Pediatric type 1 diabetes mellitus</keyword>
</DOC>